When should I start seeing results from Wegovy?

The first pen is in the fridge — and nothing seems to be happening yet

You've followed the instructions, kept your first Wegovy pen in the fridge door, injected on schedule, and now you're watching the scales and wondering whether anything is actually happening. This is the experience our prescribers hear about most weeks. The 0.25 mg starting dose exists to let your body adjust to semaglutide, not to produce immediate weight loss. Its job is to minimise the nausea and digestive discomfort that hit hardest when GLP-1 receptor agonists are introduced too quickly.

What most people do notice in those first couple of weeks is a quietening of appetite. Meals that used to feel ordinary suddenly feel like too much. The impulse to snack between meals fades. These are real, meaningful changes (your brain's hunger signalling is already being influenced) but they may not translate into visible scale movement straight away. Water retention, meal timing and natural daily fluctuations can all obscure early fat loss. If you step on the scales on day seven and nothing has moved, that is not a sign the medicine is failing.

The NHS semaglutide information page confirms that Wegovy works by slowing gastric emptying and increasing feelings of fullness, both of which take time to produce consistent, measurable results. Patience in this early phase is clinically appropriate, not a sign you need to do anything differently.

Weeks four to twelve: when most people start to see real movement

By the time your dose steps up from 0.25 mg to 0.5 mg after roughly four weeks, and then again to 1 mg, the effects on appetite and food intake tend to deepen. Most people report that this is when the scales begin to move in a way that feels steady rather than coincidental. A reduction of one to two kilograms per month in this phase is common, though some people lose more and others less.

The titration continues under your prescriber's guidance, progressing through 1.7 mg and eventually to the 2.4 mg maintenance dose over roughly sixteen to twenty weeks. Each step up typically brings a further reduction in hunger. It is also the phase where gastrointestinal side effects, nausea, constipation or loose stools, tend to be most noticeable. They usually settle within one to two weeks of each dose increase. If they do not, that is a conversation for your prescriber, not something to push through alone.

You can read more about how the full working timeline of Wegovy compares across different stages of treatment, and what affects the pace.

What the trial evidence actually shows — and what it means for you

The STEP 1 trial, published in the New England Journal of Medicine, followed adults with obesity over 68 weeks on semaglutide 2.4 mg. Average weight loss was around 15% of starting body weight. That is a meaningful figure, but it is also an average across thousands of participants: some lost considerably more, some less. The trial ran for well over a year, which tells you something important about how long on Wegovy you typically need to be before seeing results that reflect the medicine's full potential. The biggest results came from sustained treatment at maintenance dose, not from the early weeks.

People sometimes compare their four-week results with trial headlines and feel disappointed. That comparison is unfair to yourself. At four weeks most trial participants were still on the starter dose. If you want a clear picture of when you start seeing results on Wegovy, including what typically shifts first and what comes later, that page walks through the timeline in detail. If you are curious about when you start to see results from Wegovy and what the evidence says about who tends to respond best, that page goes into more detail.

The NICE appraisal of semaglutide, TA875, notes that continuing treatment should be reviewed if less than 5% weight loss has occurred after six months on the maintenance dose. That is the clinical benchmark, not a four-week weigh-in.

What can slow results down, and what you can do about it

Several things influence when you start seeing weight loss on Wegovy. Dose matters: the 0.25 mg starting pen is not expected to produce the same effect as 2.4 mg. Your starting weight matters too; people with higher starting BMIs sometimes see faster initial movement. Diet quality matters in a way that is easy to underestimate; Wegovy reduces appetite but does not override what you choose to eat when you do eat. Protein intake, hydration and avoiding high-calorie liquids tend to support better outcomes.

Sleep, stress, and certain medications can all blunt results. If you are on treatment that affects insulin sensitivity or weight regulation, your prescriber needs to know. These are not reasons to abandon treatment; they are reasons to have an open conversation with whoever is overseeing your care.

If you are considering starting Wegovy and want to understand the cost of private treatment alongside what is included, the weight-loss treatment overview covers the practical side plainly. Understanding the results people typically achieve with Wegovy, including how they vary by dose stage and lifestyle, can also help you set realistic expectations before you begin. And if you are already on treatment and have a specific concern, our aftercare team is available seven days a week. When you are ready to check whether Wegovy is clinically suitable for you, starting a free consultation with our prescribers is straightforward.